OraSure Technologies (OSUR) Sees Activist Pressure Ease After Reaching Agreement with Altai Capital
OraSure (OSUR) Q3 2026 Earnings Call Transcript
OraSure Technologies, Inc. Q3 2026 Earnings Call Summary
OraSure Technologies, Inc. (OSUR) Q3 2026 Earnings Call Transcript
OraSure Technologies Q3 Earnings Call Highlights
OraSure: Q3 Earnings Snapshot
OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion
OraSure Technologies Q3 2026 Earnings Call Transcript
OraSure Technologies Sees FY2026 Sales $120.427M vs $121.304M Est
OraSure Technologies Sees Q4 Sales $30.000M-$32.000M vs $31.701M Est
OraSure Technologies Q3 Adj. EPS $(0.15) Beats $(0.20) Estimate, Sales $30.907M Miss $31.021M Estimate
OraSure Technologies (OSUR) Stock Fair Value Rises As Testing Funding Outlook Stabilizes
OraSure Technologies Joins the World Coalition on Sickle Cell Disease to Advance Access to Earlier Diagnosis and Care
OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th
OraSure (OSUR) Returns To Profit, But Growth Remains Elusive
OraSure Technologies: Lack Of Near Term Catalysts
OraSure (OSUR) Q2 2026 Earnings Call Transcript
OraSure Technologies, Inc. Q2 2026 Earnings Call Summary
OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript
OraSure Technologies Inc (OSUR) (Q2 2026) Earnings Call Highlights: Revenue Surges 9. ...
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.